Current Issue June 2012, Vol. 76, No. 3

Issue Highlights

Reviews

Biomarkers for small cell lung cancer: Neuroendocrine, epithelial and circulating tumour cells
June 2012(Vol. 76 | No. 3 | Pages 263-268)
Rachel Stovold, Fiona Blackhall, Suzanne Meredith, JianMei Hou, Caroline Dive, Anne White

Maintenance treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology
June 2012(Vol. 76 | No. 3 | Pages 269-279)
Cesare Gridelli, Filippo de Marinis, Massimo Di Maio, Andrea Ardizzoni, Chandra P. Belani, Federico Cappuzzo, Fortunato Ciardiello, Panagiotis Fidias, Luis Paz-Ares, Francesco Perrone, Robert Pirker, Luigi De Petris, Rolf Stahel

Epidemiology

Characteristics of lung cancer in women: Importance of hormonal and growth factors
June 2012(Vol. 76 | No. 3 | Pages 280-285)
Isabelle Rouquette, Valérie Lauwers-Cances, Camille Allera, Laurent Brouchet, Julie Milia, Yvan Nicaise, Julie Laurent, Marie-Bernadette Delisle, Gilles Favre, Alain Didier, Julien Mazières

The Italian Association of Thoracic Oncology (AIOT) was founded in July 2007 in order to improve knowledge and research in the field of thoracic oncology in Italy, through the collaboration of oncologists, radiotherapists, surgeons and researchers. The aim of the association is to create a platform for cultural and scientific discussion among the different professional trainers who play an important part in the diagnostic and therapeutic runs. A further aim is to support and increase clinical research and medical training.

The AIOT is also actively involved with the Italian School of Thoracic Oncology (SIOT) located in Frascati, Rome in the wonderful area of Castelli Romani, as well as in the organization of highly qualified educational events. Moreover with 380 members, the AIOT is currently setting up an international board of key opinion leaders.

Blinded and uniform cause of death verification in a lung cancer CT screening trial
24 May 2012
N. Horeweg, R.J. van Klaveren, H.J.M. Groen, J.-W.J. Lammers, C. Weenink, K. Nackaerts, W. Mali, M. Oudkerk, H.J. de Koning
Abstract: Disease-specific mortality is the final outcome of a lung cancer screening trial, therefore cause of death verification is crucial. The use of death certificates for this purpose is debated ...
Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation
23 May 2012
June Koo Lee, Tae Min Kim, Youngil Koh, Se-Hoon Lee, Dong-Wan Kim, Yoon-Kyung Jeon, Doo Hyun Chung, Seok-Chul Yang, Young Tae Kim, Young-Whan Kim, Dae Seog Heo, Yung-Jue Bang
Abstract: Epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) translocations in non-small cell lung cancer (NSCLC) are mutually exclusive. However, several exception...
New vision, new hope: Building momentum in NSCLC
21 May 2012
- PDF (78 KB)
Non-steroidal anti-inflammatory drugs and small cell lung cancer risk in the VITAL study
21 May 2012
Theodore M. Brasky, Christina S. Baik, Christopher G. Slatore, John D. Potter, Emily White
Abstract: Few studies have examined the association between non-steroidal anti-inflammatory drug (NSAID) use and risk of small cell lung cancer (SCLC); among them, findings are mixed. Recently, we fou...
Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy
21 May 2012
Seok-Hyun Kim, Gyeong-Won Lee, Min Jeong Lee, Yu Ji Cho, Yi Yeong Jeong, Ho-Cheol Kim, Jong Duk Lee, Young Sil Hwang, In-Suk Kim, Suee Lee, Sung Yong Oh
Abstract: Background: First-line platinum-based chemotherapy is currently considered the standard treatment for unresectable non-small cell lung cancer (NSCLC). However, resistance to platinum-based c...

View More Articles in Press...

Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer
April 2012 (Vol. 76 | No. 1 | Pages 19-25)
John D. O’Flaherty, Steven Gray, Derek Richard, Dean Fennell, John J. O’Leary, Fiona H. Blackhall, Kenneth J. O’Byrne
Metastatectomy for extra-cranial extra-adrenal non-small cell lung cancer solitary metastases: Systematic review and analysis of reported cases
January 2012 (Vol. 75 | No. 1 | Pages 9-14)
Samer Salah, Tawee Tanvetyanon, Salah Abbasi
Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer
March 2012 (Vol. 75 | No. 3 | Pages 381-390)
J. Varlotto, L.N. Medford-Davis, A. Recht, J. Flickinger, E. Schaefer, J. Shelkey, M. Lazar, D. Campbell, M. Nikolov, M.M. DeCamp
MO19390 (SAiL): Bleeding events in a phase IV study of first-line bevacizumab with chemotherapy in patients with advanced non-squamous NSCLC
June 2012 (Vol. 76 | No. 3 | Pages 373-379)
Eric Dansin, Saverio Cinieri, Pilar Garrido, Frank Griesinger, Dolores Isla, Manfred Koehler, Martin Kohlhaeufl
An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls
March 2012 (Vol. 75 | No. 3 | Pages 326-331)
Silvano Dragonieri, Marc P. van der Schee, Tommaso Massaro, Nunzia Schiavulli, Paul Brinkman, Armando Pinca, Pierluigi Carratú, Antonio Spanevello, Onofrio Resta, Marina Musti, Peter J. Sterk

Most Read lists are compiled every quarter.

On the Cover

New Issue Alert

Free Trial Issue

Publishing Information

Lung Cancer is published by Elsevier for the Italian Association of Thoracic Oncology (AIOT), the International Lung Cancer Consortium (ILCCO), and the European Thoracic Oncology Platform (ETOP).

Access this journal onSciVerse ScienceDirect

About Lung Cancer

Lung Cancer aims to provide individuals or organisations with the most recent information on lung cancer and other thoracic malignancies. The Journal publishes full-length articles of original research on clinical and basic aspects of topics represented by the fields of interest of Lung Cancer (prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities). Short communications, technical notes and reviews may also be published.

Journal Access

Full-text articles are available from 1997 to the present. Access to abstracts is complimentary. Access to full text is limited to print subscribers. Register or login to:

Buy a Subscription Now

Activate Online Access